BridgeMD
New treatment option for Oral Dysplasia
Official title Topical Imiquimod Treatment of Oral Dysplasia
ClinicalTrials.gov ID: NCT07210775
What this study is testing
What is Imiquimod (topical use)?
Imiquimod (topical use) is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for oral dysplasia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to determine the effectiveness of imiquimod in treating oral dysplasia in adult patients. Imiquimod 5% cream could be a safe and practical treatment for oral epithelial dysplasia (a precancerous change in the mouth).
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- The patient has a biopsy-proven diagnosis of oral epithelial dysplasia.
- The patient is ineligible for or unwilling to undergo surgical or laser therapy.
- The patient is over 18 years old.
- The patient agrees to join the study and completes the informed consent process.
You likely can't join if
- The patient has OL, and excisional surgical removal is indicated.
- The patient is immunocompromised.
- The patient is under 18 years old.
- The patient refused to join the study or did not complete the informed consent process.
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.